Kostov AM, Jensen MB, Ejlertsen B, Thomassen M, et al. Timely germline BRCA testing after invasive breast cancer promotes contralateral
risk-reducing mastectomy and improves survival: an observational retrospective
study. Breast Cancer Res Treat 2025 May 23. doi: 10.1007/s10549-025-07726.
PMID: 40408052
|